Abstract
The present work was undertaken to test whether cytoskeletal components are involved in the control of rat-liver carnitine palmitoyltransferase I (CPT-I) activity by cellular effectors. The microtubule stabilizer taxol abolished the changes in CPT-I activity induced by the effectors tested. Taxol also prevented OA-induced shrinkage of hepatocytes as well as the enhanced release of lactate dehydrogenase from digitonin-permeabilized hepatocytes. On the basis of its relative sensitivity to tautomycin and OA, the modulation of CPT-I activity seemed to involve mostly protein phosphatase 1. These data suggest that the short-term control of hepatic CPT-I by cellular effectors may involve modulation of interactions between CPT-I and cytoskeletal components.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antifungal Agents / pharmacology
-
Bucladesine / pharmacology
-
Carnitine O-Palmitoyltransferase / metabolism*
-
Cells, Cultured
-
Cytoskeleton / drug effects
-
Cytoskeleton / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Ethers, Cyclic / pharmacology
-
Glutamine / pharmacology
-
Liver / cytology
-
Liver / enzymology*
-
Male
-
Microtubules / drug effects
-
Okadaic Acid
-
Paclitaxel / pharmacology
-
Phosphoprotein Phosphatases / antagonists & inhibitors
-
Protein Phosphatase 1
-
Pyrans*
-
Rats
-
Rats, Wistar
-
Spiro Compounds*
-
Vanadates / pharmacology
Substances
-
Antifungal Agents
-
Enzyme Inhibitors
-
Ethers, Cyclic
-
Pyrans
-
Spiro Compounds
-
Glutamine
-
tautomycin
-
Okadaic Acid
-
Vanadates
-
Bucladesine
-
Carnitine O-Palmitoyltransferase
-
Phosphoprotein Phosphatases
-
Protein Phosphatase 1
-
Paclitaxel